New Advances and Opportunities for Improvement in HR+/HER2- Early Breast Cancer PeerView Oncology 29:21 2 years ago 3 703 Скачать Далее
New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Mahtani & Dr. Schwartzberg Total Health | Oncology 1:07:43 2 years ago 2 562 Скачать Далее
New and emerging agents in HER2-negative metastatic breast cancer: Implications for practice Touch Medical Media Services 34:12 11 months ago 2 773 Скачать Далее
Important considerations in the management of HR+, HER2-negative early breast cancer VJOncology 2:05 1 year ago 5 354 Скачать Далее
Raising the Bar in HR+/HER2- Early Breast Cancer: CDK4 and 6 Inhibitors PeerView Oncology 1:09:24 2 years ago 2 040 Скачать Далее
Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast Cancer PeerView Oncology 57:18 2 years ago 2 663 Скачать Далее
Conceptualizing Guidelines to Manage Patients with HR–Positive, HER2-Negative Early Breast Cancer Medscape 30:49 Streamed 1 year ago 751 Скачать Далее
Leveraging Targeted Therapies to Improve Outcomes Across the Continuum of HER2+ Breast Cancer PeerView Oncology 1:35:31 3 years ago 737 Скачать Далее
ASCO 2023 Expert Report in HR positive, HER2 negative breast cancer by Catherine Harper-Wynne European Society for Medical Oncology (ESMO) 7:15 1 year ago 6 808 Скачать Далее
New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Kaklamani and Dr. O’Regan Total Health | Oncology 51:56 3 years ago 392 Скачать Далее
Lightning Updates | 2023 Best of Breast Conference Total Health | Oncology 20:55 1 year ago 2 282 Скачать Далее
New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Irene and Dr. Vogel Total Health | Oncology 52:21 2 years ago 652 Скачать Далее
PREDICT+ underestimates survival of patients with HER2+ early breast cancer VJOncology 4:37 3 years ago 1 650 Скачать Далее
ClarifyingComplexities of ExpandingTreatmentOptionsFor AdvancedAndEarly-Stage HR+/HER2- BreastCancer PeerView Oncology 1:40:47 1 year ago 845 Скачать Далее
Optimizing treatment in patients with early-stage HER2-positive breast cancer VJOncology 4:12 1 year ago 5 980 Скачать Далее
Samuraciclib in combination with fulvestrant in patients with advanced HR+/HER2- breast cancer VJOncology 5:02 2 years ago 358 Скачать Далее
Recent Updates in HR-Positive/HER2-Negative Early Breast Cancer: A Deep Dive Into Understanding t... Medscape 33:11 1 month ago 6 Скачать Далее
Expert Report on advances in the management of HER2-negative and HER2-low advanced breast cancer European Society for Medical Oncology (ESMO) 6:39 2 years ago 3 287 Скачать Далее
Final results from PALLAS: adjuvant palbociclib in HR+/HER2- early breast cancer VJOncology 3:30 2 years ago 366 Скачать Далее
New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Bagegni & Dr. Gradishar Total Health | Oncology 55:48 3 years ago 813 Скачать Далее
